0000950170-24-074292.txt : 20240617 0000950170-24-074292.hdr.sgml : 20240617 20240617163301 ACCESSION NUMBER: 0000950170-24-074292 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20240614 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20240617 DATE AS OF CHANGE: 20240617 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HCW Biologics Inc. CENTRAL INDEX KEY: 0001828673 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 825024477 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40591 FILM NUMBER: 241048756 BUSINESS ADDRESS: STREET 1: 2929 N COMMERCE PKWY CITY: MIRAMAR STATE: FL ZIP: 33025 BUSINESS PHONE: 954-842-2024 MAIL ADDRESS: STREET 1: 2929 N COMMERCE PKWY CITY: MIRAMAR STATE: FL ZIP: 33025 8-K 1 hcwb-20240614.htm 8-K 8-K
false000182867300018286732024-06-142024-06-14

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 14, 2024

 

 

HCW Biologics Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-40591

82-5024477

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

2929 N. Commerce Parkway

 

Miramar, Florida

 

33025

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 954 842-2024

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, par value $0.0001 per share

 

HCWB

 

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

On June 14, 2024, HCW Biologics Inc. (the “Company”) held its 2024 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the stockholders voted on the following two proposals and cast their votes as follows:

1.
The Company’s stockholders approved the election of one Class III director to serve for a three-year term expiring at the 2027 Annual Meeting of Stockholders, or until such director's successor is duly elected and qualified or until such director's earlier death, resignation, disqualification or removal:

Nominee

For

Withheld

Broker Non-Votes

Hing C. Wong

24,165,521

1,348,261

2,313,942

The director named under Proposal No. 1 was elected based on the recommendation of the Company's Board of Directors in the Company’s 2024 Proxy Statement.

2.
The Company’s stockholders ratified the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024:

For

Against

Abstain

Broker Non-Votes

27,788,079

7,646

31,999

N/A


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

HCW BIOLOGICS INC.

 

 

 

 

Date:

June 17, 2024

By:

/s/ Hing C. Wong

 

 

 

Hing. C. Wong, Ph.D.
Founder and Chief Executive Officer

 

 EX-101.SCH 2 hcwb-20240614.xsd XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT 100000 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink Cover [Abstract] Amendment Flag City Area Code Document Period End Date Document Type Entity Address, Address Line One Entity Address, City or Town Entity Address, Postal Zip Code Entity Address, State or Province Entity Central Index Key Entity Emerging Growth Company Entity Ex Transition Period Entity File Number Entity Incorporation, State or Country Code Entity Information, Former Legal or Registered Name Entity Registrant Name Entity Tax Identification Number Local Phone Number Pre-commencement Issuer Tender Offer Pre-commencement Tender Offer Title of 12(b) Security Security Exchange Name Soliciting Material Trading Symbol Written Communications XML 4 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Document And Entity Information
Jun. 14, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jun. 14, 2024
Entity Registrant Name HCW Biologics Inc.
Entity Central Index Key 0001828673
Entity Emerging Growth Company true
Entity File Number 001-40591
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 82-5024477
Entity Address, Address Line One 2929 N. Commerce Parkway
Entity Address, City or Town Miramar
Entity Address, State or Province FL
Entity Address, Postal Zip Code 33025
City Area Code 954
Local Phone Number 842-2024
Entity Information, Former Legal or Registered Name Not Applicable
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Ex Transition Period true
Title of 12(b) Security Common Stock, par value $0.0001 per share
Trading Symbol HCWB
Security Exchange Name NASDAQ
EXCEL 5 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 6 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 7 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 9 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 1 24 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document And Entity Information Sheet http://hcwbiologics.com/20240614/taxonomy/role/DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false All Reports Book All Reports hcwb-20240614.htm hcwb-20240614.xsd http://xbrl.sec.gov/dei/2024 false false JSON 11 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "hcwb-20240614.htm": { "nsprefix": "hcwb", "nsuri": "http://hcwbiologics.com/20240614", "dts": { "inline": { "local": [ "hcwb-20240614.htm" ] }, "schema": { "local": [ "hcwb-20240614.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] } }, "keyStandard": 24, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2024": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 25, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2024": 24 }, "report": { "R1": { "role": "http://hcwbiologics.com/20240614/taxonomy/role/DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "C_fd500d34-6624-4785-8b3d-036aecf6e6b4", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "hcwb-20240614.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_fd500d34-6624-4785-8b3d-036aecf6e6b4", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "hcwb-20240614.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://hcwbiologics.com/20240614/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://hcwbiologics.com/20240614/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://hcwbiologics.com/20240614/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://hcwbiologics.com/20240614/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://hcwbiologics.com/20240614/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://hcwbiologics.com/20240614/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://hcwbiologics.com/20240614/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://hcwbiologics.com/20240614/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://hcwbiologics.com/20240614/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://hcwbiologics.com/20240614/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityExTransitionPeriod", "presentation": [ "http://hcwbiologics.com/20240614/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r7" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://hcwbiologics.com/20240614/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://hcwbiologics.com/20240614/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInformationFormerLegalOrRegisteredName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInformationFormerLegalOrRegisteredName", "presentation": [ "http://hcwbiologics.com/20240614/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Information, Former Legal or Registered Name", "documentation": "Former Legal or Registered Name of an entity" } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://hcwbiologics.com/20240614/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://hcwbiologics.com/20240614/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://hcwbiologics.com/20240614/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://hcwbiologics.com/20240614/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://hcwbiologics.com/20240614/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://hcwbiologics.com/20240614/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://hcwbiologics.com/20240614/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://hcwbiologics.com/20240614/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://hcwbiologics.com/20240614/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://hcwbiologics.com/20240614/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 12 0000950170-24-074292-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-24-074292-xbrl.zip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end XML 14 hcwb-20240614_htm.xml IDEA: XBRL DOCUMENT 0001828673 2024-06-14 2024-06-14 false 0001828673 8-K 2024-06-14 HCW Biologics Inc. DE 001-40591 82-5024477 2929 N. Commerce Parkway Miramar FL 33025 954 842-2024 Not Applicable false false false false Common Stock, par value $0.0001 per share HCWB NASDAQ true true